Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

Primary non-Hodgkin's lymphoma of the breast (PBNHL) is uncommon. There have been only a few reports of breast lymphoma in the radiology literature. In this case report, we describe mammographic ...

Dave Coulier's health has seen better days. The Full House alum was diagnosed with cancer last fall and is currently ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...

Studies suggest that processed meats contain nitrates and nitrites, which can form harmful compounds that damage DNA ...

Yoanna Pumpalova, MD People infected with human immunodeficiency virus (HIV) have a substantially higher risk of certain types of cancer -Kaposi ...

WHEN doctors dismissed 13-year-old Bebe’s tiredness as anaemia, her mum had a gut feeling there must be a more serious ...

When it comes to research dollars, rare forms of cancer are often left out of the equation. That’s where grassroots ...

In the TV adaptation of Charlie Webster's viral podcast "Scamanda," ABC News rehases Amanda Riley's cancer con with a few revelations.

Primary central nervous system lymphoma (PCNSL) is a rare type of non-Hodgkin's lymphoma (NHL) confined to the nervous system. The disease is managed quite differently from other primary brain ...

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...